Tim Roloff

4.7k total citations · 2 hit papers
48 papers, 2.8k citations indexed

About

Tim Roloff is a scholar working on Molecular Biology, Infectious Diseases and Genetics. According to data from OpenAlex, Tim Roloff has authored 48 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 11 papers in Infectious Diseases and 8 papers in Genetics. Recurrent topics in Tim Roloff's work include Epigenetics and DNA Methylation (10 papers), Genomics and Chromatin Dynamics (7 papers) and Antibiotic Resistance in Bacteria (7 papers). Tim Roloff is often cited by papers focused on Epigenetics and DNA Methylation (10 papers), Genomics and Chromatin Dynamics (7 papers) and Antibiotic Resistance in Bacteria (7 papers). Tim Roloff collaborates with scholars based in Switzerland, Germany and Netherlands. Tim Roloff's co-authors include Michael Stadler, Dirk Schübeler, Fabio Mohn, Michael Rebhan, Miriam Bibel, Michaël Weber, Jens Richter, Ulrike A. Nuber, Antoine H.F.M. Peters and Hans‐Hilger Ropers and has published in prestigious journals such as Nature, Genes & Development and Molecular Cell.

In The Last Decade

Tim Roloff

46 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lineage-Specific Polycomb Targets and De Novo DNA Methylation Define Restriction and Potential of Neuronal Progenitors

2008 694 citations Tim Roloff, Dirk Schübeler et al. profile →
Repressive and active histone methylation mark distinct promoters in human and mouse spermatozoa

2010 510 citations Tim Roloff, Dirk Schübeler et al. profile →

Peers

Countries citing papers authored by Tim Roloff

Since Specialization

Citations

This map shows the geographic impact of Tim Roloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Roloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Roloff more than expected).

Fields of papers citing papers by Tim Roloff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Roloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Roloff. The network helps show where Tim Roloff may publish in the future.

Co-authorship network of co-authors of Tim Roloff

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Roloff. A scholar is included among the top collaborators of Tim Roloff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Roloff. Tim Roloff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gut-derived metabolites drive Th17 cell pathogenicity in multiple sclerosis 2025 ·Cell Reports ·(unknown), Solenne Vigne, (unknown), (unknown), Francisco Órtega Ruiz, Bastian Peter, Nancy E. Phillips, (unknown), Tim Roloff, Adrian Egli, Jens Kühle, Tinh‐Hai Collet, Anne‐Katrin Pröbstel, Caroline Pot	1
2	Evaluating methods for genome sequencing of Chlamydia trachomatis and other sexually transmitted bacteria directly from clinical swabs 2025 ·Microbial Genomics ·(unknown), (unknown), (unknown), (unknown), Frank Imkamp, Tim Roloff, Mirja Puolakkainen, Eija Hiltunen‐Back, Dominique L. Braun, (unknown), (unknown), (unknown), (unknown), (unknown), Laura Svidler López, (unknown), Adrian Egli, Marcelo Rodríguez Fermepín, Helena M. B. Seth-Smith, (unknown)	1
3	Performance of disc diffusion and gradient strip test on different Mueller–Hinton agar media plates and ComASP® and Bruker UMIC® Cefiderocol Microdilution Panels for cefiderocol susceptibility testing in carbapenem-resistant Pseudomonas aeruginosa 2025 ·Journal of Antimicrobial Chemotherapy ·Stefano Mancini, Helena M. B. Seth-Smith, (unknown), Mélanie Mermod, Vladimira Hinić, Tim Roloff, Muhammad Ali Syed, Irfan Ullah, Adrian Egli, Oliver Nolte	0
4	Novel Organism Verification and Analysis (NOVA) study: identification of 35 clinical isolates representing potentially novel bacterial taxa using a pipeline based on whole genome sequencing 2024 ·BMC Microbiology ·(unknown), Helena M. B. Seth-Smith, (unknown), Maja Weisser, Vladimira Hinić, (unknown), Tim Roloff, Ulrich Heininger, Hanna Schmid, (unknown), (unknown), (unknown), (unknown), Daniel Goldenberger	4
5	Evaluation of DNA extraction kits for long-read shotgun metagenomics using Oxford Nanopore sequencing for rapid taxonomic and antimicrobial resistance detection 2024 ·Scientific Reports ·(unknown), Marco Meola, Tim Roloff, (unknown), Adrian Egli	5
6	S-Gene Target Failure as an Effective Tool for Tracking the Emergence of Dominant SARS-CoV-2 Variants in Switzerland and Liechtenstein, Including Alpha, Delta, and Omicron BA.1, BA.2, and BA.4/BA.5 2024 ·Microorganisms ·(unknown), Faina Wehrli, (unknown), (unknown), Thomas Bodmer, Helena M. B. Seth-Smith, Tim Roloff, Philipp Köhler, Christian R. Kahlert, Laurent Kaiser, Adrian Egli, Lorenz Risch, Martin Risch, Nadia Wohlwend	1
7	Factors impacting the pre-analytical quality of blood cultures—Analysis at a tertiary medical center 2023 ·PLoS ONE ·(unknown), Laura Werlen, Nikki Rommers, (unknown), (unknown), Stefano Bassetti, Roland Bingisser, Martin Siegemund, Tim Roloff, Maja Weisser, (unknown), Vladimira Hinić, Michael Osthoff, Fabian Franzeck, Adrian Egli	2
8	PorinPredict: In Silico Identification of OprD Loss from WGS Data for Improved Genotype-Phenotype Predictions of P. aeruginosa Carbapenem Resistance 2023 ·Microbiology Spectrum ·Michael Biggel, Sophia Johler, Tim Roloff, Sarah Tschudin‐Sutter, Stefano Bassetti, Martin Siegemund, Adrian Egli, Roger Stephan, Helena M. B. Seth-Smith	11
9	Gut microbiota composition as a candidate risk factor for dimethyl fumarate-induced lymphopenia in multiple sclerosis 2022 ·Gut Microbes ·Martin Diebold, Marco Meola, (unknown), (unknown), (unknown), Tim Roloff, Raija L.P. Lindberg, Jens Kühle, Ludwig Kappos, Tobias Derfuß, Adrian Egli, Anne‐Katrin Pröbstel	16
10	Outbreak investigation including molecular characterization of community associated methicillin-resistant Staphylococcus aureus in a primary and secondary school in Eastern Switzerland 2022 ·Scientific Reports ·(unknown), Salomé N. Seiffert, (unknown), (unknown), (unknown), Christoph Berger, Werner C. Albrich, Matthias Schlegel, Tim Roloff, Adrian Egli, Oliver Nolte, Christian R. Kahlert	2
11	Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay 2020 ·Journal of Virological Methods ·Daniel Goldenberger, Karoline Leuzinger, Kirstine K. Søgaard, Rainer Gosert, Tim Roloff, Klaudia Naegele, Aline Cuénod, Alfredo Mari, Helena M. B. Seth-Smith, Katharina Rentsch, Vladimira Hinić, Hans H. Hirsch, Adrian Egli	33
12	Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 Emergence Amidst Community-Acquired Respiratory Viruses 2020 ·The Journal of Infectious Diseases ·Karoline Leuzinger, Tim Roloff, Rainer Gosert, (unknown), Klaudia Naegele, Katharina Rentsch, Roland Bingisser, Christian H. Nickel, Hans Pargger, Stefano Bassetti, Julia Bielicki, Nina Khanna, Sarah Tschudin‐Sutter, Andreas F. Widmer, Vladimira Hinić, Manuel Battegay, Adrian Egli, Hans H. Hirsch	54
13	Chronic expression of wild-type Ret receptor in the mammary gland induces luminal tumors that are sensitive to Ret inhibition 2018 ·Oncogene ·(unknown), (unknown), Tim Roloff, Robert D. Cardiff, Edith C. Kordon, Lewis A. Chodosh, Nancy E. Hynes	12
14	Regulating Repression: Roles for the Sir4 N-Terminus in Linker DNA Protection and Stabilization of Epigenetic States 2012 ·PLoS Genetics ·Stephanie Kueng, Monika Tsai-Pflugfelder, Mariano Oppikofer, Helder Ferreira, (unknown), (unknown), Tim Roloff, Ragna Sack, Susan M. Gasser	16
15	Polycomb function during oogenesis is required for mouse embryonic development 2012 ·Genes & Development ·Eszter Pósfai, (unknown), Vincent Brochard, Juliette Salvaing, Erik Cabuy, Tim Roloff, Zichuan Liu, Mathieu Tardat, Maarten van Lohuizen, Miguel Vidal, Nathalie Beaujean, Antoine H.F.M. Peters	107
16	Phenobarbital Mediates an Epigenetic Switch at the Constitutive Androstane Receptor (CAR) Target Gene Cyp2b10 in the Liver of B6C3F1 Mice 2011 ·PLoS ONE ·Harri Lempiäinen, Arne Müller, (unknown), Soon-Siong Teo, Tim Roloff, (unknown), Natasa Zamurovic, (unknown), (unknown), Philippe Couttet, Dirk Schübeler, Olivier Grenet, Jennifer Marlowe, Jonathan G. Moggs, Rémi Terranova	63
17	Histone Deacetylase 6 (HDAC6) Is an Essential Modifier of Glucocorticoid-Induced Hepatic Gluconeogenesis 2011 ·Diabetes ·(unknown), Verena Benz, Markus Clemenz, (unknown), Anna Foryst‐Ludwig, (unknown), Nicole Witte, (unknown), Pawel Namsolleck, Knut Mai, Joachim Spranger, Gabriele Matthias, Tim Roloff, (unknown), Kai Kappert, Michael Schupp, Patrick Matthias, Ulrich Kintscher	70
18	Nuclear Retention of Fission Yeast Dicer Is a Prerequisite for RNAi-Mediated Heterochromatin Assembly 2010 ·Developmental Cell ·(unknown), Heiko Schober, Dimos Gaidatzis, Tim Roloff, (unknown), Marc Bühler	73
19	Chromatin, epigenetics and stem cells 2005 ·European Journal of Cell Biology ·Tim Roloff, Ulrike A. Nuber	30
20	Evidence against the functional involvement of outwardly rectifying Cl− channels in agonist-induced mast cell exocytosis 2001 ·European Journal of Pharmacology ·Tim Roloff, (unknown), Albrecht Ziegler, Jörg Seebeck	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact